DataMeds AI, Inc. SEC filings MEDS
DataMeds AI, Inc. has 176 filings in SEC EDGAR's recent list, going back to Jul 22, 2024. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (agreement ended, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Nov 5, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 26, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Material agreement, Listing notice, Unregistered share sale
|
Oct 16, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Other events
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Other events
|
Sep 17, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Sep 16, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 18, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Other events
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 4, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Other events
|
Jul 29, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 21, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Jun 12, 2026 | Jun 9, 2026 |
| 8-K/A | Amended current report | Jun 3, 2026 | May 27, 2026 |
| 8-K/A | Amended current report | Jun 2, 2026 | May 27, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 29, 2026 | May 27, 2026 |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 21, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
|
May 21, 2026 | May 19, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 19, 2026 | May 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2026 | May 15, 2026 |
| 8-K |
Current report
Other events
|
May 18, 2026 | May 18, 2026 |
| 8-K |
Current report
Material agreement
|
May 7, 2026 | May 1, 2026 |
| 8-K/A |
Amended current report
Material agreement
|
May 4, 2026 | Feb 9, 2026 |
| 8-K/A |
Amended current report
Material agreement, Listing notice, Unregistered share sale, Regulation FD disclosure
|
Apr 21, 2026 | Apr 17, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 17, 2026 | Apr 17, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 9, 2026 | Apr 3, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 7, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 11, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Feb 13, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 9, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2026 | Feb 1, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 20, 2026 | Jan 16, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Jan 8, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 19, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Listing notice
|
Dec 16, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 26, 2025 | Nov 26, 2025 |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure
|
Nov 26, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 25, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 20, 2025 | Nov 20, 2025 |
| 8-K |
Current report
Auditor change
|
Nov 17, 2025 | Nov 11, 2025 |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2025 | Oct 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 22, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2025 | Oct 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 6, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 1, 2025 | Sep 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2025 | Sep 5, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 29, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 22, 2025 | Aug 20, 2025 |
| 8-K |
Current report
Agreement ended, Officer or director change, Regulation FD disclosure
|
Aug 14, 2025 | Aug 8, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 30, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Auditor change
|
Jul 8, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Apr 24, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 18, 2025 | Apr 14, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Apr 11, 2025 | Apr 8, 2025 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure
|
Mar 27, 2025 | Mar 21, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 21, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Mar 6, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 28, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 26, 2025 | Feb 20, 2025 |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- MEDS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tampa, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2030763
- Former names
- Wellgistics Health, Inc. (until Jul 21, 2026); Danam Health, Inc (until Sep 27, 2024)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.